Today in Banking
SEE OTHER BRANDS

Reporting on banking news in the world

Allegro MicroSystems Reports Second Quarter 2026 Results

Sales Increased 14% Year-Over-Year to $214 Million

MANCHESTER, N.H., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its second quarter ended September 26, 2025.

“We delivered strong second quarter results, with sales of $214 million, up 14% year-over-year, and led by growth in both e-Mobility and Industrial & Other, increasing 21% and 23% year-over-year, respectively. Non-GAAP EPS was $0.13, increasing more than 60% year-over-year,” said Mike Doogue, President and CEO of Allegro. “We saw broad strength in second quarter Automotive sales with growth in e-Mobility and Other Auto, while data center delivered record sales to fuel year-over-year growth in Industrial. In addition to this strong financial performance, year-to-date design wins are well ahead of fiscal 2025, with second quarter wins led by e-Mobility and data center."

Second Quarter Financial Highlights:

In thousands, except per share data   Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Net Sales                              
Automotive   $ 155,845     $ 144,264     $ 139,680     $ 300,109     $ 267,074  
Industrial and Other     58,449       59,141       47,711       117,590       87,236  
Total net sales   $ 214,294     $ 203,405     $ 187,391     $ 417,699     $ 354,310  
GAAP Financial Measures                              
Gross margin %     46.3 %     44.9 %     45.7 %     45.6 %     45.3 %
Operating margin %     2.9 %     (1.3 )%     2.2 %     0.8 %     (1.9 )%
Diluted EPS   $ 0.03     $ (0.07 )   $ (0.18 )   $ (0.04 )   $ (0.27 )
Non-GAAP Financial Measures                              
Gross margin %     49.6 %     48.2 %     48.8 %     48.9 %     48.8 %
Operating margin %     13.9 %     11.1 %     11.7 %     12.5 %     9.0 %
Diluted EPS   $ 0.13     $ 0.09     $ 0.08     $ 0.21     $ 0.11  


Business Outlook

For the third quarter of fiscal year 2026 ending December 26, 2025, the Company expects total net sales to be in the range of
$215 million to $225 million. At the midpoint of this range, it implies growth in net sales of 24% year-over-year.

The Company also estimates the following results on a non-GAAP basis:

  • Gross Margin is expected to be between 49% and 51%,
  • Interest expense is expected to be approximately $5 million, and
  • Diluted Earnings per Share is expected to be between $0.12 and $0.16.

Allegro has not provided a reconciliation of its third fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Interest Expense, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.

Earnings Webcast

A webcast will be held on Thursday, October 30, 2025 at 8:30 a.m., Eastern Time. Michael C. Doogue, President and Chief Executive Officer, and Derek P. D’Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems, Inc. is leveraging more than three decades of expertise in magnetic sensing and power ICs, to propel automotive, clean energy and industrial automation forward with solutions that enhance efficiency, performance and sustainability. Allegro’s commitment to quality drives transformation across industries, reinforcing our status as a pioneer in “automotive grade” technology and a partner in our customers’ success. For additional information, please visit https://www.allegromicro.com.

Forward-Looking Statements        

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 28, 2025, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix, customer mix or channel mix, which could negatively impact our gross margin; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control impacting us, our key suppliers or our manufacturing partners; our ability to develop new product features or new products in a timely and cost-effective manner; our dependence on growth in the end markets that use our products and the impact that slowdowns in such growth could have on our financial results; the loss of one or more significant customers; our ability to identify, enter and expand in new markets, and to generate returns on such investments; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the risk of unsolicited acquisition proposals; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to retain key and highly skilled personnel; the impact of restructuring activities on our business and operating results; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or confidential information or those of our third-party service providers; any failure to maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; the risks presented by climate change; the risks related to ESG matters; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their most directly comparable GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.

ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share amounts)
(Unaudited)
 
             
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
Net sales   $ 214,294     $ 187,391     $ 417,699     $ 354,310  
Cost of goods sold     115,002       101,729       227,105       193,877  
Gross profit     99,292       85,662       190,594       160,433  
Operating expenses:                        
Research and development     50,891       43,510       97,391       88,714  
Selling, general and administrative     42,158       38,085       89,700       78,282  
Total operating expenses     93,049       81,595       187,091       166,996  
Operating income (loss)     6,243       4,067       3,503       (6,563 )
Interest and other expense     (8,958 )     (12,398 )     (16,211 )     (18,341 )
Loss on change in fair value of forward repurchase contract           (34,752 )           (34,752 )
Loss before income taxes     (2,715 )     (43,083 )     (12,708 )     (59,656 )
Income tax benefit     (9,298 )     (9,470 )     (6,129 )     (8,430 )
Net income (loss)     6,583       (33,613 )     (6,579 )     (51,226 )
Net income attributable to non-controlling interests     64       62       129       124  
Net income (loss) attributable to Allegro MicroSystems, Inc.   $ 6,519     $ (33,675 )   $ (6,708 )   $ (51,350 )
Net income (loss) per common share attributable to Allegro MicroSystems, Inc.:                        
Basic   $ 0.04     $ (0.18 )   $ (0.04 )   $ (0.27 )
Diluted   $ 0.03     $ (0.18 )   $ (0.04 )   $ (0.27 )
Weighted average shares outstanding:                        
Basic     185,074,119       189,182,850       184,830,588       191,324,281  
Diluted     186,305,785       189,182,850       184,830,588       191,324,281  


Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited condensed consolidated statements of operations:

    Three-Month Period Ended     Change     Six-Month Period Ended     Change  
    September 26, 2025     September 27, 2024     Amount     %     September 26, 2025     September 27, 2024     Amount     %  
    (Dollars in thousands)     (Dollars in thousands)  
Automotive   $ 155,845     $ 139,680     $ 16,165       12 %   $ 300,109     $ 267,074     $ 33,035       12 %
Industrial and Other     58,449       47,711       10,738       23 %     117,590       87,236       30,354       35 %
Total net sales   $ 214,294     $ 187,391     $ 26,903       14 %   $ 417,699     $ 354,310     $ 63,389       18 %


ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
    September 26,     March 28,  
    2025
(Unaudited)
    2025  
Assets            
Current assets:            
Cash and cash equivalents   $ 117,492     $ 121,334  
Restricted cash     9,322       9,773  
Trade accounts receivable, net     105,770       84,598  
Inventories     170,681       183,914  
Prepaid income taxes     9,363       36,662  
Prepaid expenses and other current assets     40,324       30,247  
Assets held for sale     16,508       16,508  
Total current assets     469,460       483,036  
Property, plant and equipment, net     300,438       302,919  
Deferred income tax assets     72,955       68,528  
Goodwill     203,467       202,475  
Intangible assets, net     250,929       262,115  
Equity investment in related party     28,542       31,695  
Other assets     58,537       70,193  
Total assets   $ 1,384,328     $ 1,420,961  
Liabilities, Non-Controlling Interest and Stockholders’ Equity            
Current liabilities:            
Trade accounts payable   $ 41,761     $ 38,733  
Amounts due to related party     3,263       6,535  
Accrued expenses and other current liabilities     74,082       65,570  
Current portion of long-term debt     1,553       1,423  
Total current liabilities     120,659       112,261  
Long-term debt     286,135       344,703  
Other long-term liabilities     31,705       32,897  
Total liabilities     438,499       489,861  
Commitments and contingencies            
Stockholders’ Equity:            
Preferred stock            
Common stock     1,851       1,843  
Additional paid-in capital     1,029,002       1,012,055  
Accumulated deficit     (60,299 )     (53,591 )
Accumulated other comprehensive loss     (26,379 )     (30,752 )
Equity attributable to Allegro MicroSystems, Inc.     944,175       929,555  
Non-controlling interest     1,654       1,545  
Total stockholders’ equity     945,829       931,100  
Total liabilities, non-controlling interest and stockholders’ equity   $ 1,384,328     $ 1,420,961  


ALLEGRO MICROSYSTEMS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
             
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
Cash flows from operating activities:                        
Net income (loss)   $ 6,583     $ (33,613 )   $ (6,579 )   $ (51,226 )
Adjustments to reconcile net income (loss) to net cash provided by operating activities:                        
Depreciation and amortization     16,611       15,997       32,827       32,455  
Amortization of deferred financing costs     717       306       1,650       1,087  
Deferred income taxes     890       (2,796 )     (4,171 )     (7,795 )
Stock-based compensation     13,681       11,545       24,443       21,663  
Loss on change in fair value of forward repurchase contract           34,752             34,752  
Provisions for inventory and expected credit losses     1,093       2,111       4,543       4,488  
Other non-cash reconciling items     217       6,563       159       6,577  
Changes in operating assets and liabilities:                        
Trade accounts receivable     (16,391 )     (13,717 )     (21,723 )     41,417  
Inventories     2,020       (2,845 )     9,253       (18,831 )
Prepaid expenses and other assets     (9,338 )     (14,093 )     26,627       (15,808 )
Trade accounts payable     (2,100 )     13,470       4,181       13,670  
Due to and from related parties     361       695       (3,272 )     4,132  
Other changes in operating assets and liabilities, net     6,018       (2,828 )     14,042       (16,838 )
Net cash provided by operating activities     20,362       15,547       81,980       49,743  
Cash flows from investing activities:                        
Purchases of property, plant and equipment     (6,444 )     (9,972 )     (17,044 )     (20,949 )
Net cash used in investing activities     (6,444 )     (9,972 )     (17,044 )     (20,949 )
Cash flows from financing activities:                        
Net proceeds from Refinanced 2023 Term Loan Facility           193,483             193,483  
Repayment of term loan     (25,000 )           (60,000 )     (50,000 )
Finance lease payments     (336 )     (240 )     (538 )     (385 )
Receipts on related party notes receivable           937             1,875  
Payments for contingent consideration     (1,000 )           (1,000 )      
Payments for taxes related to net share settlement of equity awards     (361 )     (1,126 )     (9,349 )     (12,297 )
Proceeds from issuance of common stock under employee stock purchase plan     1,910       1,987       1,910       1,987  
Repurchases of common stock           (853,805 )           (853,805 )
Payments for taxes related to repurchase of common stock     (1,713 )           (1,713 )      
Net proceeds from issuance of common stock           665,850             665,850  
Dividends paid to non-controlling interest     (23 )           (23 )      
Net cash (used in) provided by financing activities     (26,523 )     7,086       (70,713 )     (53,292 )
Effect of exchange rate changes on cash and cash equivalents and restricted cash     40       2,200       1,484       1,375  
Net (decrease) increase in cash and cash equivalents and restricted cash     (12,565 )     14,861       (4,293 )     (23,123 )
Cash and cash equivalents and restricted cash at beginning of period     139,379       184,177       131,107       222,161  
Cash and cash equivalents and restricted cash at end of period   $ 126,814     $ 199,038     $ 126,814     $ 199,038  


Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision, non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as a percentage of net sales (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision, management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related-party activities and other non-operational costs.

Non-GAAP Income Tax Provision

In calculating the non-GAAP Income Tax Provision, we adjust for the tax effect of adjustments to GAAP results which represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below. We also adjust for any discrete tax items and the impact of non-recurring tax law changes to ensure the non-GAAP Income Tax Rate (“NG ETR”) reflects future operations.

Our fiscal year 2026 and 2027 NG ETR excludes the impact of the 2025 One Big Beautiful Bill Act’s one-time research and development amortization election which accelerates the amortization of previously capitalized domestic research and development over a two-year period. The NG ETR is applied to non-GAAP Profit before Tax to arrive at the tax effect of adjustments to GAAP results.

Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin  
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Gross Profit   $ 99,292     $ 91,302     $ 85,662     $ 190,594     $ 160,433  
GAAP Gross Margin (% of net sales)     46.3 %     44.9 %     45.7 %     45.6 %     45.3 %
                               
Non-GAAP adjustments                              
Transaction-related costs                 10             9  
Purchased intangible amortization     5,090       5,089       4,875       10,179       9,750  
Restructuring costs     751       705       16       1,456       1,216  
Stock-based compensation     1,017       888       817       1,905       1,378  
Other Costs     44                   44        
Total Non-GAAP Adjustments   $ 6,902     $ 6,682     $ 5,718     $ 13,584     $ 12,353  
                               
Non-GAAP Gross Profit   $ 106,194     $ 97,984     $ 91,380     $ 204,178     $ 172,786  
Non-GAAP Gross Margin (% of net sales)     49.6 %     48.2 %     48.8 %     48.9 %     48.8 %


Reconciliation of Non-GAAP Operating Expenses  
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Operating Expenses   $ 93,049     $ 94,042     $ 81,595     $ 187,091     $ 166,996  
                               
Research and Development Expenses                              
GAAP Research and Development Expenses     50,891       46,500       43,510       97,391       88,714  
Non-GAAP adjustments                              
Transaction-related costs                 206             1,235  
Purchased intangible amortization     8       3             11        
Restructuring costs     1,639       1,131       260       2,770       429  
Stock-based compensation     4,907       2,911       3,523       7,818       7,258  
Other costs(1)     112       35       3       147       3  
Non-GAAP Research and Development Expenses     44,225       42,420       39,518       86,645       79,789  
                               
Selling, General and Administrative Expenses                              
GAAP Selling, General and Administrative Expenses     42,158       47,542       38,085       89,700       78,282  
Non-GAAP adjustments                              
Transaction-related costs     1       130       275       131       1,089  
Purchased intangible amortization     535       535       535       1,070       1,070  
Restructuring costs     1,158       1,184       2,046       2,342       3,091  
Stock-based compensation     7,757       6,963       7,205       14,720       13,027  
Other costs(1)     476       5,838       (1,820 )     6,314       (1,009 )
Non-GAAP Selling, General and Administrative Expenses     32,231       32,892       29,844       65,123       61,014  
                               
Total Non-GAAP Adjustments     16,593       18,730       12,233       35,323       26,193  
                               
Non-GAAP Operating Expenses   $ 76,456     $ 75,312     $ 69,362     $ 151,768     $ 140,803  
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.  


Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin  
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Operating Income (Loss)   $ 6,243     $ (2,740 )   $ 4,067     $ 3,503     $ (6,563 )
GAAP Operating Margin (% of net sales)     2.9 %     (1.3 )%     2.2 %     0.8 %     (1.9 )%
                               
Transaction-related costs     1       130       491       131       2,333  
Purchased intangible amortization     5,633       5,627       5,410       11,260       10,820  
Restructuring costs     3,548       3,020       2,322       6,568       4,736  
Stock-based compensation     13,681       10,762       11,545       24,443       21,663  
Other costs(1)     632       5,873       (1,817 )     6,505       (1,006 )
Total Non-GAAP Adjustments   $ 23,495     $ 25,412     $ 17,951     $ 48,907     $ 38,546  
                               
Non-GAAP Operating Income   $ 29,738     $ 22,672     $ 22,018     $ 52,410     $ 31,983  
Non-GAAP Operating Margin (% of net sales)     13.9 %     11.1 %     11.7 %     12.5 %     9.0 %
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.  


Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin  
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Net Income (Loss)   $ 6,583     $ (13,162 )   $ (33,613 )   $ (6,579 )   $ (51,226 )
GAAP Net Income (Loss) Margin (% of net sales)     3.1 %     (6.5 )%     (17.9 )%     (1.6 )%     (14.5 )%
                               
Interest expense     5,730       6,359       10,353       12,089       15,730  
Interest income     (159 )     (234 )     (420 )     (393 )     (914 )
Income tax (benefit) provision     (9,298 )     3,169       (9,470 )     (6,129 )     (8,430 )
Depreciation & amortization     16,611       16,216       15,997       32,827       32,455  
EBITDA   $ 19,467     $ 12,348     $ (17,153 )   $ 31,815     $ (12,385 )
                               
Transaction-related costs     1       130       3,295       131       5,137  
Restructuring costs     3,403       2,824       2,067       6,227       4,481  
Stock-based compensation     13,681       10,762       11,545       24,443       21,663  
Loss on change in fair value of forward repurchase contract                 34,752             34,752  
Other costs(1)     4,271       7,304       (2,195 )     11,575       612  
Adjusted EBITDA   $ 40,823     $ 33,368     $ 32,311     $ 74,191     $ 54,260  
Adjusted EBITDA Margin (% of net sales)     19.0 %     16.4 %     17.2 %     17.8 %     15.3 %
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.  


Reconciliation of Non-GAAP Profit before Tax  
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Loss before Income Taxes   $ (2,715 )   $ (9,993 )   $ (43,083 )   $ (12,708 )   $ (59,656 )
                               
Transaction-related costs     1       130       3,295       131       5,137  
Transaction-related interest     645       860       141       1,505       850  
Purchased intangible amortization     5,633       5,627       5,410       11,260       10,820  
Restructuring costs     3,736       3,020       2,067       6,756       4,481  
Stock-based compensation     13,681       10,762       11,545       24,443       21,663  
Loss on change in fair value of forward repurchase contract                 34,752             34,752  
Other costs(1)     4,271       7,304       1,428       11,575       4,235  
Total Non-GAAP Adjustments   $ 27,967     $ 27,703     $ 58,638     $ 55,670     $ 81,938  
                               
Non-GAAP Profit before Tax   $ 25,252     $ 17,710     $ 15,555     $ 42,962     $ 22,282  
                               
(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.  


Reconciliation of Non-GAAP Income Tax Provision and Non-GAAP Effective Tax Rate  
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Income Tax (Benefit) Provision   $ (9,298 )   $ 3,169     $ (9,470 )   $ (6,129 )   $ (8,430 )
GAAP effective tax rate     342.5 %     (31.7 )%     22.0 %     48.2 %     14.1 %
                               
Tax effect of adjustments to GAAP results     10,733       (1,483 )     10,071       9,250       9,676  
                               
Non-GAAP Income Tax Provision   $ 1,435     $ 1,686     $ 601     $ 3,121     $ 1,246  
Non-GAAP effective tax rate     5.7 %     9.5 %     3.9 %     7.3 %     5.6 %


Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share  
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Net Income (Loss) Attributable to Allegro MicroSystems, Inc.(1)   $ 6,519     $ (13,227 )   $ (33,675 )   $ (6,708 )   $ (51,350 )
GAAP Basic weighted average common shares     185,074,119       184,587,027       189,182,850       184,830,588       191,324,281  
GAAP Diluted weighted average common shares     186,305,785       184,587,027       189,182,850       184,830,588       191,324,281  
GAAP Basic Income (Loss) per Share   $ 0.04     $ (0.07 )   $ (0.18 )   $ (0.04 )   $ (0.27 )
GAAP Diluted Income (Loss) per Share   $ 0.03     $ (0.07 )   $ (0.18 )   $ (0.04 )   $ (0.27 )
                               
Transaction-related costs     1       130       3,295       131       5,137  
Transaction-related interest     645       860       141       1,505       850  
Purchased intangible amortization     5,633       5,627       5,410       11,260       10,820  
Restructuring costs     3,736       3,020       2,067       6,756       4,481  
Stock-based compensation     13,681       10,762       11,545       24,443       21,663  
Loss on change in fair value of forward repurchase contract                 34,752             34,752  
Other costs(2)     4,271       7,304       1,428       11,575       4,235  
Total Non-GAAP Adjustments     27,967       27,703       58,638       55,670       81,938  
Tax effect of adjustments to GAAP results(3)     (10,733 )     1,483       (10,071 )     (9,250 )     (9,676 )
Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc.   $ 23,753     $ 15,959     $ 14,892     $ 39,712     $ 20,912  
Basic weighted average common shares     185,074,119       184,587,027       189,182,850       184,830,588       191,324,281  
Diluted weighted average common shares     186,305,785       185,416,258       189,710,595       185,800,398       192,154,185  
Non-GAAP Basic Earnings per Share   $ 0.13     $ 0.09     $ 0.08     $ 0.21     $ 0.11  
Non-GAAP Diluted Earnings per Share   $ 0.13     $ 0.09     $ 0.08     $ 0.21     $ 0.11  
                               
(1) GAAP Net Income (Loss) Attributable to Allegro MicroSystems, Inc. represents GAAP Net Income (Loss) adjusted for Net Income Attributable to non-controlling interests.  
(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.  
(3) To calculate the tax effect of adjustments to GAAP results, the Company considers each Non-GAAP adjustment by tax jurisdiction, reverses all discrete items, non-recurring law changes to calculate an annual NG ETR. This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.  


Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales        
                               
    Three-Month Period Ended     Six-Month Period Ended  
    September 26, 2025     June 27, 2025     September 27, 2024     September 26, 2025     September 27, 2024  
    (Dollars in thousands)     (Dollars in thousands)  
GAAP Operating Cash Flow   $ 20,362     $ 61,618     $ 15,547     $ 81,980     $ 49,743  
GAAP Operating Cash Flow (% of net sales)     9.5 %     30.3 %     8.3 %     19.6 %     14.0 %
Non-GAAP adjustments                              
Purchases of property, plant and equipment     (6,444 )     (10,600 )     (9,972 )     (17,044 )     (20,949 )
Non-GAAP Free Cash Flow   $ 13,918     $ 51,018     $ 5,575     $ 64,936     $ 28,794  
Non-GAAP Free Cash Flow (% of net sales)     6.5 %     25.1 %     3.0 %     15.5 %     8.1 %

Investor Contact:
Jalene Hoover
VP of Investor Relations & Corporate Communications
+1 (512) 751-6526
jhoover@allegromicro.com 


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions